Cancer

Reimagining diagnostics: Why AI is essential for the future of NHS pathology

AI-powered pathology presents the NHS with a unique opportunity to enhance cancer detection. Paige AI explains how its tools can facilitate quicker diagnostics and improve cost efficiency within the UK’s health system.

Japan: Driving forward cancer research through collaboration

The work of the Japanese Cancer Association in driving forward cancer research through collaboration is charted here, including a push on basic and translational research.

The advancement of cancer research for the public benefit

European Association for Cancer Research’s Chief Executive Officer, Jane Smith, explains why the advancement of cancer research is purely for the public benefit, as well as the importance of collaboration in the field.

Employing “living biobanks” to advance biomedical research

A group of seasoned experts from the International Society for Biological and Environmental Repositories explain the notion of employing “living biobanks” to advance the field of biomedical research.

New drugs could stop ovarian cancer

Researchers at The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

Insights into the mechanisms of primary brain tumour invasion

Thomas Daubon, Clotilde Billottet and Andreas Bikfalvi at the Angiogenesis and Tumor Microenvironment-INSERM U1029, Université Bordeaux provide insights into the mechanisms of primary brain tumour invasion.

Genetic link to leukaemia in children with Down’s syndrome

Researchers at the University of Oxford have found that there is a gene link to leukaemia, already present in children with Down's syndrome.

Tackling sepsis through hand hygiene

Chris Wakefield, Vice President, European Marketing & Product Development, at GOJO Industries-Europe Ltd explores hand hygiene and how infection prevention measures can be strengthened to help save lives.

Research reveals masterswitch in body’s immune system

Scientists have discovered a critical masterswitch in the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.

The challenges of living with a diagnosis of Cancer and Dementia

For this year’s World Cancer Day, we spoke to Admiral Nurse, Debby Veigas, around the challenges that caring for someone with dementia and cancer brings.

Parents call for teachers to teach children about the signs and symptoms of cancer

Two-thirds of parents think teachers should teach school children about the signs and symptoms of cancer, it has emerged

Spotlight on tea’s top healthy ingredients

Tea is the nation’s favourite drink and for good reason: it not only tastes great, but it’s good for our wellbeing as it is full of healthy ingredients.

A trans-disciplinary approach to cancer research

The use of a trans-disciplinary approach to cancer research is necessary for complex systems like tumors.

ChiLTERN: European project to improve outcome of children with liver cancer

In this analysis, Professor Keith Wheatley tells us about The ChiLTERN project, the most comprehensive research study ever undertaken in children’s liver cancer

Point-of-care devices technology for therapeutic drug monitoring in cancer treatment and beyond

Christian Siebel and Dott.ssa Bianca Posocco detail the work of DIACHEMO, a Euroepan project developing a platform technology for point-of-care devices for chemotherapeutics and other drugs.

Bowel cancer – time to test at an earlier age

Your toilet habits can help determine what is going on inside your body and with Brits spending the equivalent of eight months of their adult life sat on the toilet, it is time to test for bowel cancer at an earlier age

Biomarkers and patients’ access to personalised oncology drugs in Europe

Heinz Zwierzina M.D., CDDF Managing Director tells us all about biomarkers and patients’ access to personalised oncology drugs in Europe in this insightful article

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders